|
⚲
|
| Keyboard |
| McMurdo Matthew Charles
✚
|
|
|---|---|
| CIK # | 0001943108 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001943108] | |
| 4 | [0001943108] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McMurdo Matthew Charles | |
| Indaptus Therapeutics Inc | |
| Minim Inc | |
| Opgen Inc | |
| Titan Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Minim Inc MINM
Common Stock
|
2024-09-26 | Grant | 159,364 | ||
|
Opgen Inc OPGN
Common Stock
|
2024-04-11 | Grant | 100,000 | ||
|
Minim Inc MINM
Common Stock
|
2024-01-22 | Grant | 25,000 | ||
|
Titan Pharmaceuticals Inc TTNP
Common Stock
|
2023-10-25 | Grant | 16,250 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP
Common Stock
|
2023-07-26 | Grant | 50,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
|
2023-06-29 | Grant | 25,000 | $0.00 | |
|
Titan Pharmaceuticals Inc TTNP
Option to Purchase Common Stock · derivative
|
2023-06-29 | Grant | 100,000 | $0.00 |